AstraZeneca Will Use Accelrys Software to Speed Drug Discovery

Jan 29, 2002

NEW YORK, Jan. 29 - Accelrys has struck a global licensing agreement with AstraZeneca, the informatics firm said on Tuesday.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.